RDY Net Debt from 2010 to 2025

RDY Stock

USD 13.71 0.13 0.96%

Dr Reddys Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2025. Net Debt is the total debt of Dr Reddys Laboratories minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2001-06-30

Previous Quarter

37.2 B

Current Value

38.8 B

Quarterly Volatility

46.5 B

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0271 or PTB Ratio of 0.86. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.

Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Net Debt Growth Pattern

Below is the plot of the Net Debt of Dr Reddys Laboratories over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Dr Reddys' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Net Debt

Timeline

RDY Net Debt Regression Statistics

	Arithmetic Mean	35,913,227,937
	Coefficient Of Variation	211.49
	Mean Deviation	36,590,414,523
	Median	15,479,000,000
	Standard Deviation	75,954,631,822
	Sample Variance	5769106095.2T
	Range	322.7B
	R-Value	(0.26)
	Mean Square Error	5761750248.2T
	R-Squared	0.07
	Significance	0.33
	Slope	(4,155,820,848)
	Total Sum of Squares	86536591428.2T

RDY Net Debt History

	2025	27.4 B
	2024	14.8 B
	2023	12.9 B
	2022	7.7 B
	2021	19 B
	2020	15.5 B
	2019	20 B

Other Fundumenentals of Dr Reddys Laboratories

Net Debt To E B I T D A

Dr Reddys Net Debt component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Net Receivables	Good Will	Total Current Assets	Treasury Stock	Short Term Debt	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.1	0.97	-0.15	0.93	0.97	0.89	0.95	-0.06	-0.04	0.93	0.98	0.98	1.0	-0.06	0.93	0.07	-0.04	0.13	-0.18	-0.16	0.17	0.14	0.12	0.16
Total Stockholder Equity	0.98		0.29	0.91	-0.16	0.97	0.89	0.86	0.87	0.1	0.07	0.84	0.93	0.91	0.99	-0.23	0.83	0.22	0.08	0.01	-0.21	-0.1	0.19	0.31	0.29	0.3
Retained Earnings	0.1	0.29		-0.11	0.05	0.35	-0.15	0.07	-0.2	0.84	0.58	-0.24	-0.04	-0.11	0.13	-0.83	-0.26	0.69	0.63	-0.55	-0.06	0.33	0.04	0.83	0.85	0.7
Accounts Payable	0.97	0.91	-0.11		-0.13	0.85	1.0	0.9	0.99	-0.22	-0.15	0.97	0.99	0.99	0.96	0.11	0.97	-0.03	-0.15	0.24	-0.14	-0.22	0.15	0.0	-0.02	0.0
Long Term Debt	-0.15	-0.16	0.05	-0.13		-0.24	-0.13	0.18	-0.16	0.38	0.07	-0.06	-0.18	-0.15	-0.19	0.12	-0.16	-0.01	0.19	-0.21	0.99	0.44	-0.49	-0.13	-0.13	-0.07
Short Term Investments	0.93	0.97	0.35	0.85	-0.24		0.83	0.74	0.81	0.07	-0.01	0.76	0.88	0.85	0.95	-0.22	0.76	0.2	-0.03	-0.08	-0.3	-0.12	0.37	0.39	0.37	0.38
Total Liab	0.97	0.89	-0.15	1.0	-0.13	0.83		0.89	1.0	-0.25	-0.16	0.98	0.99	0.99	0.95	0.15	0.99	-0.08	-0.16	0.26	-0.14	-0.23	0.12	-0.07	-0.09	-0.04
Intangible Assets	0.89	0.86	0.07	0.9	0.18	0.74	0.89		0.85	0.11	0.04	0.88	0.89	0.88	0.86	-0.01	0.85	0.11	0.16	0.14	0.17	-0.02	-0.07	0.07	0.07	0.04
Common Stock	0.95	0.87	-0.2	0.99	-0.16	0.81	1.0	0.85		-0.31	-0.21	0.98	0.97	0.99	0.94	0.2	0.99	-0.14	-0.23	0.29	-0.16	-0.26	0.14	-0.13	-0.15	-0.06
Property Plant Equipment	-0.06	0.1	0.84	-0.22	0.38	0.07	-0.25	0.11	-0.31		0.64	-0.3	-0.17	-0.22	-0.06	-0.71	-0.33	0.71	0.76	-0.51	0.33	0.67	-0.24	0.59	0.62	0.45
Current Deferred Revenue	-0.04	0.07	0.58	-0.15	0.07	-0.01	-0.16	0.04	-0.21	0.64		-0.22	-0.06	-0.13	-0.03	-0.81	-0.23	0.62	0.74	-0.42	0.08	0.34	-0.58	0.38	0.46	0.07
Net Debt	0.93	0.84	-0.24	0.97	-0.06	0.76	0.98	0.88	0.98	-0.3	-0.22		0.94	0.97	0.91	0.23	0.98	-0.17	-0.19	0.37	-0.06	-0.3	0.07	-0.18	-0.19	-0.09
Net Receivables	0.98	0.93	-0.04	0.99	-0.18	0.88	0.99	0.89	0.97	-0.17	-0.06	0.94		0.98	0.97	0.03	0.95	0.04	-0.1	0.17	-0.19	-0.19	0.14	0.07	0.06	0.03
Good Will	0.98	0.91	-0.11	0.99	-0.15	0.85	0.99	0.88	0.99	-0.22	-0.13	0.97	0.98		0.96	0.11	0.98	-0.07	-0.15	0.24	-0.15	-0.21	0.13	-0.06	-0.08	-0.01
Total Current Assets	1.0	0.99	0.13	0.96	-0.19	0.95	0.95	0.86	0.94	-0.06	-0.03	0.91	0.97	0.96		-0.09	0.91	0.1	-0.04	0.11	-0.23	-0.18	0.2	0.18	0.16	0.19
Treasury Stock	-0.06	-0.23	-0.83	0.11	0.12	-0.22	0.15	-0.01	0.2	-0.71	-0.81	0.23	0.03	0.11	-0.09		0.26	-0.84	-0.76	0.39	0.18	-0.25	0.19	-0.76	-0.81	-0.42
Short Term Debt	0.93	0.83	-0.26	0.97	-0.16	0.76	0.99	0.85	0.99	-0.33	-0.23	0.98	0.95	0.98	0.91	0.26		-0.21	-0.22	0.34	-0.15	-0.26	0.13	-0.2	-0.23	-0.11
Net Tangible Assets	0.07	0.22	0.69	-0.03	-0.01	0.2	-0.08	0.11	-0.14	0.71	0.62	-0.17	0.04	-0.07	0.1	-0.84	-0.21		0.68	-0.22	-0.07	0.41	-0.16	0.76	0.8	0.41
Long Term Investments	-0.04	0.08	0.63	-0.15	0.19	-0.03	-0.16	0.16	-0.23	0.76	0.74	-0.19	-0.1	-0.15	-0.04	-0.76	-0.22	0.68		-0.08	0.16	0.27	-0.36	0.51	0.53	0.25
Short Long Term Debt	0.13	0.01	-0.55	0.24	-0.21	-0.08	0.26	0.14	0.29	-0.51	-0.42	0.37	0.17	0.24	0.11	0.39	0.34	-0.22	-0.08		-0.18	-0.56	0.03	-0.39	-0.43	-0.27
Long Term Debt Total	-0.18	-0.21	-0.06	-0.14	0.99	-0.3	-0.14	0.17	-0.16	0.33	0.08	-0.06	-0.19	-0.15	-0.23	0.18	-0.15	-0.07	0.16	-0.18		0.45	-0.53	-0.25	-0.24	-0.2
Capital Surpluse	-0.16	-0.1	0.33	-0.22	0.44	-0.12	-0.23	-0.02	-0.26	0.67	0.34	-0.3	-0.19	-0.21	-0.18	-0.25	-0.26	0.41	0.27	-0.56	0.45		-0.26	0.1	0.13	0.03
Cash And Equivalents	0.17	0.19	0.04	0.15	-0.49	0.37	0.12	-0.07	0.14	-0.24	-0.58	0.07	0.14	0.13	0.2	0.19	0.13	-0.16	-0.36	0.03	-0.53	-0.26		0.26	0.2	0.26
Net Invested Capital	0.14	0.31	0.83	0.0	-0.13	0.39	-0.07	0.07	-0.13	0.59	0.38	-0.18	0.07	-0.06	0.18	-0.76	-0.2	0.76	0.51	-0.39	-0.25	0.1	0.26		0.98	0.72
Net Working Capital	0.12	0.29	0.85	-0.02	-0.13	0.37	-0.09	0.07	-0.15	0.62	0.46	-0.19	0.06	-0.08	0.16	-0.81	-0.23	0.8	0.53	-0.43	-0.24	0.13	0.2	0.98		0.65
Capital Stock	0.16	0.3	0.7	0.0	-0.07	0.38	-0.04	0.04	-0.06	0.45	0.07	-0.09	0.03	-0.01	0.19	-0.42	-0.11	0.41	0.25	-0.27	-0.2	0.03	0.26	0.72	0.65

Click cells to compare fundamentals

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	14.8 B	27.4 B
Net Debt To EBITDA	0.13	0.18

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
S	SentinelOne
GM	General Motors

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

RDY Net Debt from 2010 to 2025

Latest Dr Reddys' Net Debt Growth Pattern

RDY Net Debt Regression Statistics

RDY Net Debt History

Other Fundumenentals of Dr Reddys Laboratories

Dr Reddys Net Debt component correlations

About Dr Reddys Financial Statements

Also Currently Popular

Additional Tools for RDY Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY